Brent Robertson, MD
Vascular Surgery · Conroe, TXNPI 1780112276
Payments from drug & device makers
Across 172 payments — averaging $66.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- W. L. Gore & Associates, Inc.$1K
- Cook Medical LLC$890
- Penumbra, Inc.$805
- Abbott$586
- Boston Scientific$436
- plus $2K from 26 others
What the payments were for
- Grants$8337%
- Travel & lodging$1,0559%
- Food & beverage$9,53283%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 85 | $5,389 |
| W. L. Gore & Associates, Inc. | 14 | $1,243 |
| Cook Medical LLC | 3 | $890 |
| Penumbra, Inc. | 7 | $805 |
| Abbott | 6 | $586 |
| Boston Scientific | 4 | $436 |
| Inari Medical, Inc. | 6 | $429 |
| Silk Road Medical, Inc. | 3 | $297 |
| Johnson & Johnson(2 entities) | 11 | $186 |
| Surmodics, Inc. | 2 | $144 |
| BD | 1 | $138 |
| Lemaitre Vascular, Inc. | 1 | $110 |
| Angiodynamics, Inc. | 3 | $86 |
| Globus Medical | 2 | $82 |
| Artivion, Inc. | 1 | $72 |
| Organogenesis Inc. | 2 | $67 |
| Tactile Systems Technology Inc | 3 | $59 |
| Inspiremd Ltd | 1 | $57 |
| Aroa Biosurgery Incorporated | 2 | $55 |
| Merck | 3 | $43 |
| Cardiovascular Systems Inc. | 1 | $33 |
| Bolton Medical Inc | 1 | $30 |
| Regeneron | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Argon Medical Devices, Inc. | 1 | $19 |
| Integra Lifesciences Corporation | 1 | $18 |
| Pfizer | 1 | $17 |
| Cashflow Solutions, LLC | 1 | $17 |
| AbbVie | 1 | $17 |
| Novo Nordisk | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| KCI USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Abre$1,695
- TurboHawk$974
- Indigo System$619
- ENDURANT IIS$460
- GORE VIABAHN VBX Balloon Expandable Endo$399
- HawkOne$264
- Perclose ProGlide suture mediated closure system$259
- ENROUTE Transcarotid Neuroprotection System$175
- ENROUTE Transcarotid Stent$175
- GORE TAG Thoracic Branch Endoprosthesis$163
- GORE EXCLUDER Iliac Branch Endoprosthesis$162
- FLOWTRIEVER CATHETER, S$151
- CT THROMBECTOMY SYSTEM KIT$151
- AMPLATZER Occluders$146
- Penumbra System$143
- Supera peripheral stent system$140
- Lutonix Drug Coated Balloon$138
- IN.PACT Admiral$135
- Valiant Captivia$132
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$122
How this compares
$11,421 in reported general payments places this provider in the 60th percentile of 347 vascular surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 45 | $25,286 |
| XareltoRivaroxaban | 11 | $9,172 |
| Atorvastatin Calcium | 21 | $341 |
| ClopidogrelClopidogrel Bisulfate | 37 | $279 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $17 | $25,28645 claims |
| Johnson & JohnsonXarelto | $186 | $9,17211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 347 vascular surgery providers in Texas.
Other vascular surgery in Conroe
- Mazin FotehAustin$2.5M
- Alan LumsdenHouston$2.4M
- Gregory PearlDallas$2.3M
- Gustavo OderichHouston$999K
- Michael SiahDallas$838K
- Stephen HohmannDallas$587K
- Dennis GableDallas$547K
- Carlos TimaranDallas$527K
- Samuel LeonardHouston$431K
- Ali AzizzadehHouston$387K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.